{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:49:54Z","timestamp":1761562194070,"version":"3.41.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s11255-017-1509-y","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T20:32:51Z","timestamp":1484598771000},"page":"587-595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mechanisms of inhibitory action of TRK-130 (Naltalimide), a \u03bc-opioid receptor partial agonist, on the micturition reflex"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-6981","authenticated-orcid":false,"given":"Morihiro","family":"Fujimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Izumimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayoko","family":"Kanie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Momen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikito","family":"Hirakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikazu","family":"Komagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Okanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadatoshi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"key":"1509_CR1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.urology.2003.09.008","volume":"62","author":"AJ Wein","year":"2003","unstructured":"Wein AJ (2003) Diagnosis and treatment of the overactive bladder. Urology 62:20\u201327","journal-title":"Urology"},{"key":"1509_CR2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0022-5347(05)00313-7","volume":"175","author":"AJ Wein","year":"2006","unstructured":"Wein AJ, Rackley RR (2006) Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol 175:S5\u2013S10","journal-title":"J Urol"},{"key":"1509_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejogrb.2013.12.024","volume":"174","author":"LMA Cipullo","year":"2014","unstructured":"Cipullo LMA, Cosimato C, Filippelli A, Conti V, Izzo V, Zullo F, Guida M (2014) Pharmacological approach to overactive bladder and urge urinary incontinence in women: an overview. Eur J Obstet Gynecol Reprod Biol 174:27\u201334","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1509_CR4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00228-008-0600-9","volume":"65","author":"S Brostr\u00f8m","year":"2009","unstructured":"Brostr\u00f8m S, Hallas J (2009) Persistence of antimuscarinic drug use. Eur J Clin Pharmacol 65:309\u2013314","journal-title":"Eur J Clin Pharmacol"},{"key":"1509_CR5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1742-1241.2010.02626.x","volume":"65","author":"CC Sexton","year":"2011","unstructured":"Sexton CC, Notte SM, Maroulis C, Dmochowski RR, Cardozo L, Subramanian D, Coyne KS (2011) Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. Int J Clin Pract 65:567\u2013585","journal-title":"Int J Clin Pract"},{"key":"1509_CR6","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.clinthera.2013.08.017","volume":"35","author":"MB Chancellor","year":"2013","unstructured":"Chancellor MB, Migliaccio-Walle K, Bramley TJ, Chaudhari SL, Corbell C, Globe D (2013) Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder. Clin Ther 35:1744\u20131751","journal-title":"Clin Ther"},{"key":"1509_CR7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/ijcp.12194","volume":"67","author":"VW Nitti","year":"2013","unstructured":"Nitti VW, Khullar V, van Kerrebroeck P, Herschorn S, Cambronero J, Angulo JC, Blauwet MB, Dorrepaal C, Siddiqui E, Martin NE (2013) Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies. Int J Clin Pract 67:619\u2013632","journal-title":"Int J Clin Pract"},{"key":"1509_CR8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0022-3565(25)21580-4","volume":"231","author":"A Dray","year":"1984","unstructured":"Dray A, Metsch R (1984) Inhibition of urinary bladder contractions by a spinal action of morphine and other opioids. J Pharmacol Exp Ther 231:254\u2013260","journal-title":"J Pharmacol Exp Ther"},{"key":"1509_CR9","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0022-3565(25)11422-5","volume":"260","author":"C Soulard","year":"1992","unstructured":"Soulard C, Pascaud X, Roman FJ, Grouhel A, Junien JL (1992) Pharmacological evaluation of JO 1870: relation to the potential treatment of urinary bladder incontinence. J Pharmacol Exp Ther 260:1152\u20131158","journal-title":"J Pharmacol Exp Ther"},{"key":"1509_CR10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/jpet.114.214031","volume":"350","author":"M Fujimura","year":"2014","unstructured":"Fujimura M, Izumimoto N, Momen S, Yoshikawa S, Kobayashi R, Kanie S, Hirakata M, Komagata T, Okanishi S, Hashimoto T, Yoshimura N, Kawai K (2014) Characteristics of TRK-130 (Naltalimide), a novel opioid ligand, as a new therapeutic agent for overactive blaidder. J Pharmacol Exp Ther 350:543\u2013551","journal-title":"J Pharmacol Exp Ther"},{"key":"1509_CR11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0014-2999(00)00177-1","volume":"395","author":"T Doi","year":"2000","unstructured":"Doi T, Kamo I, Imai S, Okanishi S, Ikeura Y, Natsugari H (2000) Effects of TAK-637, a tachykinin receptor antagonist, on the micturition reflex in guinea pigs. Eur J Pharmcol 395:241\u2013246","journal-title":"Eur J Pharmcol"},{"key":"1509_CR12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2004.05.007","volume":"494","author":"H Nagabukuro","year":"2004","unstructured":"Nagabukuro H, Okanishi S, Doi T (2004) Effects of TAK-802, a novel acetylcholinesterase inhibitor, and various cholinomimetics on the urodynamic characteristics in anesthetized guinea pigs. Eur J Pharmcol 494:225\u2013232","journal-title":"Eur J Pharmcol"},{"key":"1509_CR13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0014-2999(92)90630-M","volume":"213","author":"K Morikawa","year":"1992","unstructured":"Morikawa K, Hashimoto S, Yamauchi T, Kato H, Ito Y, Gomi Y (1992) Inhibitory effect of inaperisone hydrochloride (inaperisone), a new centrally acting muscle relaxant, on the micturition reflex. Eur J Pharmacol 213:409\u2013415","journal-title":"Eur J Pharmacol"},{"key":"1509_CR14","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/0024-3205(86)90217-1","volume":"38","author":"GW Pasternak","year":"1986","unstructured":"Pasternak GW, Wood PJ (1986) Multiple mu opiate receptors. Life Sci 38:1889\u20131898","journal-title":"Life Sci"},{"key":"1509_CR15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-6147(00)01616-3","volume":"22","author":"GW Pasternak","year":"2001","unstructured":"Pasternak GW (2001) Incomplete cross tolerance and multiple mu opioid peptide receptors. Trends Pharmacol Sci 22:67\u201370","journal-title":"Trends Pharmacol Sci"},{"key":"1509_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/syn.10277","volume":"51","author":"EA Bolan","year":"2004","unstructured":"Bolan EA, Pan YX, Pasternak GW (2004) Functional analysis of MOR-1 splice variants of the mouse mu opioid receptor gene Oprm. Synapse 51:11\u201318","journal-title":"Synapse"},{"key":"1509_CR17","first-page":"323","volume":"120","author":"LM Lee","year":"2012","unstructured":"Lee LM, Lin CS, Chung HH, Lin KC, Cheng JT (2012) Urinary bladder relaxation through activation of opioid \u00b5-receptors induced by loperamide is increased in diabetic rats. Exp Clin Endocrinol Diabetes 120:323\u2013328","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1509_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(00)02770-0","volume":"881","author":"S Sakurada","year":"2000","unstructured":"Sakurada S, Hayashi T, Yuhki M, Fujimura T, Murayama K, Yonezawa A, Sakurada C, Takeshita M, Zadina JE, Kastin AJ, Sakurada T (2000) Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone. Brain Res 881:1\u20138","journal-title":"Brain Res"},{"key":"1509_CR19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0196-9781(02)00016-5","volume":"23","author":"S Sakurada","year":"2002","unstructured":"Sakurada S, Hayashi T, Yuhki M, Fujimura T, Murayama K, Yonezawa A, Sakurada C, Takeshita M, Sato T, Zadina JE, Kastin AJ, Sakurada T (2002) Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methoxynaltrexone. Peptides 23:895\u2013901","journal-title":"Peptides"},{"key":"1509_CR20","doi-asserted-by":"crossref","first-page":"e62028","DOI":"10.1371\/journal.pone.0062028","volume":"8","author":"XL Dou","year":"2013","unstructured":"Dou XL, Qin RL, Qu J, Liao YH, Lu YC, Zhang T, Shao C, Li YQ (2013) Synaptic connections between endomorphin 2-immunoreactive terminals and \u00b5-opioid receptor-expressing neurons in the sacral parasympathetic nucleus of the rat. PLoS ONE 8:e62028","journal-title":"PLoS ONE"},{"key":"1509_CR21","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.pain.2014.06.011","volume":"155","author":"DG Soergel","year":"2014","unstructured":"Soergel DG, Subach RA, Burnham N, Lark MW, James IE, Sadler BM, Skobieranda F, Violin JD, Webster LR (2014) Biased agonism of the \u00b5-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers. Pain 155:1829\u20131835","journal-title":"Pain"},{"key":"1509_CR22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(84)90559-6","volume":"297","author":"A Dray","year":"1984","unstructured":"Dray A, Metsch R (1984) Morphine and the centrally-mediated inhibition of urinary bladder motility in the rat. Brain Res 297:191\u2013195","journal-title":"Brain Res"},{"key":"1509_CR23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(84)90367-4","volume":"104","author":"A Dray","year":"1984","unstructured":"Dray A, Metsch R (1984) Opioid receptor subtypes involved in the central inhibition of urinary bladder motility. Eur J Pharmacol 104:47\u201353","journal-title":"Eur J Pharmacol"},{"key":"1509_CR24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0143-4179(85)90006-X","volume":"6","author":"C Gouarderes","year":"1985","unstructured":"Gouarderes C, Cros J, Quirion R (1985) Autoradiographic localization of mu, delta and kappa opioid receptor binding sites in rat and guinea pig spinal cord. Neuropeptides 6:331\u2013342","journal-title":"Neuropeptides"},{"key":"1509_CR25","first-page":"R98","volume":"269","author":"E Asselt Van","year":"1995","unstructured":"Van Asselt E, Groen J, Van Mastrigt R (1995) A comparative study of voiding in rat and guinea pig: simultaneous measurement of flow rate and pressure. Am J Physiol 269:R98\u2013R103","journal-title":"Am J Physiol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1509-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-017-1509-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1509-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T14:36:06Z","timestamp":1749911766000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-017-1509-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1509"],"URL":"https:\/\/doi.org\/10.1007\/s11255-017-1509-y","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"type":"print","value":"0301-1623"},{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2017,1,16]]}}}